GLIAMED
GliaMed is a development-stage biopharmaceutical company dedicated to the discovery and development of small molecule drugs which enhance the human body’s innate ability to regenerate. Founded in 2001, the company is focused on the development of compounds termed Regenerative Immunophilin Ligands or RILs. In preclinical models, treatment with RILs has been shown to induce the localized expression of transcription factors characteristic of pluripotent stem cells at the site of acute disease or trauma.
GLIAMED
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2001-01-01
Address:
San Jose, California, United States
Country:
United States
Website Url:
http://www.gliamed.com
Total Employee:
1+
Status:
Active
Contact:
(408) 457-8828
Email Addresses:
[email protected]
Technology used in webpage:
Nginx GoDaddy SSL Media Temple MediaTemple DNS
Similar Organizations
GlycoDesign
GlycoDesign is a biopharmaceutical company, engages in the discovery and development of proprietary drugs for the treatment.
Leadiant Biosciences
Leadiant Biosciences is a pharmaceutical company dedicated to the development, registration and commercialization of effective therapies.
Suvica
Suvica is a biotechnology company that is focused on the discovery and development of small molecules for the treatment of cancer.
Theracrine
Theracrine Inc. is a private biopharmaceutical company dedicated to the discovery and development of novel therapeutics in the emerging
Official Site Inspections
http://www.gliamed.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 13.248.169.48
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "GliaMed"
GliaMed - Crunchbase Company Profile & Funding
GliaMed is a development-stage biopharmaceutical company dedicated to the discovery and development of small molecule drugs which enhance the human body’s innate ability to …See details»
GliaMed, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore GliaMed, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, and 1 literature, Drug:GM-1485, GM-1108, GM-1416. Biomedical products. ... The statistics for …See details»
GliaMed Company Profile 2024: Valuation, Funding & Investors
Nov 19, 2017 GliaMed General Information Description. Developer of regenerative immunophilin ligands intended to provide stem cell therapy and tissue regeneration. The company's therapy …See details»
GliaMed Inc - Company Profile and News - Bloomberg Markets
Company profile page for GliaMed Inc including stock price, company news, executives, board members, and contact informationSee details»
GLIAMED, INC. :: Massachusetts (US) - OpenCorporates
Free and open company data on Massachusetts (US) company GLIAMED, INC. (company number 000999558), 495 OLD CONNECTICUT PATH STE 320, FRAMINGHAM, MA, 01701. …See details»
GliaMed Company Profile | Management and Employees List
Find contact information for GliaMed. Learn about their Business Services market share, competitors, and GliaMed's email format.See details»
GliaMed - Crunchbase
GliaMed is a development-stage biopharmaceutical company dedicated to the discovery and development of small molecule drugs which enhance ... Solutions. Products. Resources. …See details»
GM-1485 - Drug Targets, Indications, Patents - Synapse - Patsnap
Active Organization-Inactive Organization. GliaMed, Inc. Arisyn Therapeutics Inc Eisai Co., Ltd. + [2] Drug Highest Phase Discontinued Phase 2. First Approval Date-Regulation-Login to view …See details»
Gliamed - Company Profile - Tracxn
Gliamed - Small molecule drugs enhancing human body's ability to regenerate. This company is not active anymore. Raised a total funding of $2.47M over 1 round. Founded by David …See details»
GliaMed - Tech Stack, Apps, Patents & Trademarks - Crunchbase
GliaMed is a development-stage biopharmaceutical company dedicated to the discovery and development of small molecule drugs which enhance. Search Crunchbase. Start Free Trial . …See details»
GliaMed, Inc. Asset Profile - Preqin
Founded in 2001 and based in California, US, GliaMed, Inc. is a biopharmaceutical company that engages in the development of drugs for the improvement of the...See details»
Corporate Profile: GliaMed - thelabrat.com
Corporate Profile: GliaMed. Summary: GliaMed is a focused the discovery and development of small molecule drugs which enable stem cell therapy. Address (HQ): 1072 S De Anza …See details»
GliaMed - Products, Competitors, Financials, Employees, …
GliaMed aims to develop regeneration through the activation and differentiation of endogenous, local stem cells. Use the CB Insights Platform to explore GliaMed's full profile.See details»
Gliamed - Raised $2.47M Funding from investors - Tracxn
Oct 20, 2024 Gliamed has raised a total funding of $2.47M over 1 round. Their latest funding round was of $2.47M on May 01, 2009 .See details»
Gliamed, Inc. in North Miami Beach FL - Company Profile
Gliamed, Inc. Overview. Gliamed, Inc. filed as a Foreign for Profit Corporation in the State of Florida and is no longer active.This corporate entity was filed approximately twenty-three years …See details»
GM-1416 - Drug Targets, Indications, Patents - Synapse - Patsnap
GM-1416, Initially developed by GliaMed, Inc., Now, its global highest R&D status is Pending, Therapeutic Areas: Nervous System Diseases,Cardiovascular Diseases. ... Originator …See details»
Glia
When you shop at our Online Shop, you're not just getting high-quality and affordable products – you're fueling our mission to revolutionize the medical community with open-source …See details»
Glia's Humanitarian Odyssey: From Innovation to Crisis Response
Mar 18, 2024 Article Written By:Carrie WakemExecutive Director, Glia From its inception, Glia’s mission to research and manufacture medical devices has been driven by a commitment to …See details»
Support Glia's Mission
At Glia, our mission is clear - equal care for all. We are dedicated to creating high-quality, affordably priced, accessible medical devices for everyone, everywhere. To increase our reach …See details»
Mechanisms of Rhodopsin-Related Inherited Retinal Degeneration …
1 day ago Treatment with JC3 and JC4 enhanced retinal structural organization and increased the intensity of visual responses compared to vehicle-treated controls. Safety evaluations …See details»